Wheatley MedTech Partners

Wheatley MedTech Partners operates as a dedicated venture capital fund, specializing in strategic investments within the medical technology sector. The firm provides essential capital to developing companies, enabling the advancement of innovative healthcare solutions and products. Their investment approach targets high-potential firms poised to introduce significant advancements in medical diagnostics, devices, and digital health across various therapeutic areas.

The firm originated from Wheatley Partners, established in 1992 by co-founders Barry Fingerhut, Seth Lieber, Jonathan Lieber, Barry Rubenstein, and Irwin Lieber. These seasoned professionals identified an opportunity to support emerging businesses, subsequently extending their focus to the specialized and rapidly evolving landscape of healthcare technology. This foundation laid the groundwork for the creation of the dedicated MedTech fund.

Although Wheatley MedTech Partners is no longer actively making new investments, it continues to support and manage its existing portfolio of medical technology companies. The firm's enduring commitment is to nurture these ventures through their growth phases, aiming to bring their innovative solutions to market and contribute to improved patient outcomes. Its current focus remains on the strategic oversight and value realization of its established investments.